Cargando…
Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells
OBJECTIVE: To test the effectiveness of combining conventional antineoplastic drugs (cisplatin and etoposide) with metformin in the treatment of non-small cell lung cancer in the NCI-H460 cell line, in order to develop new therapeutic options with high efficacy and low toxicity. METHODS: We used the...
Autores principales: | Teixeira, Sarah Fernandes, Guimarães, Isabella dos Santos, Madeira, Klesia Pirola, Daltoé, Renata Dalmaschio, Silva, Ian Victor, Rangel, Leticia Batista Azevedo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Pneumologia e Tisiologia
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075897/ https://www.ncbi.nlm.nih.gov/pubmed/24473757 http://dx.doi.org/10.1590/S1806-37132013000600002 |
Ejemplares similares
-
In vitro antineoplastic activity in triple-negative breast cancer cell line and in vivo
por: Madeira, Klesia, et al.
Publicado: (2014) -
Combined anticancer activity of osthole and cisplatin in NCI-H460 lung cancer cells in vitro
por: XU, XIAO-MAN, et al.
Publicado: (2013) -
Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI‐H460 cells by repressing MAP kinase pathways and inflammatory mediators
por: Dai, Bingling, et al.
Publicado: (2017) -
Sufentanil impairs autophagic degradation and inhibits cell migration in NCI-H460 in vitro
por: Jiang, Hui, et al.
Publicado: (2019) -
FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide
por: Ma, Jian, et al.
Publicado: (2017)